April 27, 2020 / 8:17 PM / a month ago

BRIEF-Quotient Ltd Announces Sars-Cov-2 (Covid-19) Antibody Test Final Performance Data

April 27 (Reuters) - Quotient Ltd:

* QUOTIENT LIMITED ANNOUNCES SARS-COV-2 (COVID-19) ANTIBODY TEST FINAL PERFORMANCE DATA

* QUOTIENT -EXPECTS TO COMPLETE CE MARKING PROCESS, SUBMISSION OF FDA EMERGENCY USE AUTHORIZATION FOR MOSAIQ COVID-19 ANTIBODY MICROARRAY IN A FEW DAYS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below